By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is that the article's discussion on SpaceX's IPO, valuation, and dilution is flawed due to SpaceX's current private status and the speculative nature of the article's claims. They agree that the article is not a reliable source of analysis for SpaceX's future as a public company.
Risk: Treating a hypothetical IPO scenario as imminent and discussing its dilution and valuation without a legitimate S-1 filing.
Opportunity: None explicitly stated, as the article's content is largely dismissed as fiction.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Well, that didn't take long.
On Tuesday, June 23, its sixth full day of trading, the stock of Space Exploration Technologies Corp. (NASDAQ: SPCX), or SpaceX, briefly dipped to an all-time low of $147.55/share, below its debut price of $150/share. Since then, it hasn't closed above $157/share.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
But is this price drop actually a buying opportunity in disguise? Here's what investors should know about SpaceX's prospects moving forward.
SpaceX's shares shot up to an intraday high of $176.52/share just after it began trading on Friday, June 12. Many observers thought that might be the high-water mark for the stock.
But SpaceX surprised everyone over the following two days as its stock price rocketed up to close at $211.39/share on Tuesday. This briefly put its market capitalization at $2.6 trillion, surpassing Amazon to become the fifth-largest company in the world. Analysts began to wonder if the classic trajectory of a hot IPO -- a brief Day 1 share price spike followed by a long, gradual decline -- didn't apply to SpaceX.
That dream was short-lived. The decline began the very next trading day, with shares eventually closing below $160/share on June 22, where they've mostly stayed since.
So, is now a good time to buy shares?
There are two compelling reasons to stay away from SpaceX shares right now: dilution and lockup expiration.
Dilution comes from additional share issuances. SpaceX's recent agreement to acquire artificial intelligence developer Anysphere in a $60 billion all-stock deal already requires the issuance of about 400 million new shares. An additional preexisting deal for wireless spectrum will require the issuance of $11.1 billion in new shares in 2027. And various executive bonuses, stock options, settlements, and other awards totaling about $150 billion in new shares could be issued under certain conditions as well. These issuances will likely drive the share price lower.
Meanwhile, a healthy chunk of SpaceX's existing shares are currently on "lockup." Those shares will begin unlocking two trading days after SpaceX's Q2 earnings report, which is likely to occur in late July. Additional shares unlock throughout the year until the big 180-day lockup period expiration (for employees and most pre-IPO investors) on Dec. 8. Elon Musk's shares won't unlock until June 2027.
Given widespread concerns about the company's sky-high valuation, there will be strong incentives for shareholders to sell their shares as soon as their lockups expire, which would put more near-term downward pressure on the stock.
In other words, if you want to buy and hold SpaceX shares for life, waiting at least until Dec. 9, after all those new shares have flooded the market, is likely to get you a better price than buying now. And waiting until 2027, when all shares are unlocked, and we'll have a year of quarterly numbers to help us evaluate the stock price, is probably an even smarter move.
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $398,052! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,181,688!
Now, it’s worth noting Stock Advisor’s total average return is 892% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 30, 2026. *
John Bromels has positions in Amazon. The Motley Fool has positions in and recommends Amazon. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The article is factually incorrect because SpaceX has not conducted an IPO and does not trade on the NASDAQ."
This article is fundamentally flawed because it treats SpaceX as a public company, which it is not. SpaceX remains a private entity; there is no 'SPCX' ticker on the NASDAQ. The entire premise of an IPO, share dilution, and lockup expirations is a fabrication. Investors cannot buy SpaceX stock on public exchanges. The piece relies on a 'get rich quick' narrative typical of clickbait, conflating private valuation rounds with public market trading. Any discussion regarding its $2.6 trillion market cap or share price movement is speculative fiction. Investors should ignore this noise and focus on the reality that SpaceX is currently inaccessible to retail capital outside of secondary market private equity platforms.
If one assumes the article is a thought experiment on potential future IPO mechanics, the primary risk is ignoring the massive moat SpaceX holds in launch costs and Starlink's recurring revenue, which could justify a premium regardless of technical dilution.
"The article correctly identifies dilution and lockup risk but ignores that SpaceX's actual business momentum could overwhelm those headwinds, making the 'wait until 2027' thesis overconfident."
This article is a Motley Fool promotional piece masquerading as analysis. The core claim—wait for lockup expiration and dilution to settle—is reasonable but incomplete. SpaceX's valuation at $2.6T was absurd (higher than Amazon despite $0 revenue as a public company), so mean reversion was inevitable. But the article conflates a speculative IPO pop with fundamental weakness. SpaceX has real cash flow from Starshield and commercial launches. The $60B Anysphere deal and $150B in conditional stock awards sound alarming until you ask: are those actually likely to be issued, or worst-case scenarios? The article doesn't distinguish. Also missing: SpaceX's near-term catalysts (Starship cadence, Starlink profitability, government contracts) that could re-rate the stock regardless of dilution timing.
If SpaceX's core business (launch services, Starlink) accelerates faster than dilution compounds, waiting until 2027 for 'a year of quarterly numbers' means missing a 3-5x move; Netflix and Nvidia examples prove timing the bottom is often worse than buying early volatility.
"SpaceX has not gone public, rendering every price target and dilution timeline in the article unverifiable fiction."
The article assumes SpaceX has already IPO'd as SPCX with a $2.6T peak valuation and faces immediate dilution from a $60B Anysphere deal plus 2027 spectrum issuance. In reality SpaceX remains private, so all price levels, lockup dates, and trading data are invented. Even in a future IPO scenario the piece ignores Starlink's recurring revenue ramp and NASA/DoD contracts that could offset share issuance far better than the article allows. The Motley Fool promo framing further suggests marketing copy rather than analysis of actual public space equities.
If an IPO does occur on similar terms, the sheer volume of unlocks and executive awards could still overwhelm fundamentals and force a re-rating regardless of contract backlog.
"Near-term downside risk from dilution and lockups is real, but the stock’s fate hinges on whether SpaceX can generate durable cash flow and meaningful revenue diversification to justify a re-rating."
The article highlights near-term headwinds: dilution from new issuances and lockup expiries create predictable share-price pressure after a heated IPO run. It also leans into a classic IPO overhang narrative, which historically proves overblown if fundamentals improve. What’s missing: SpaceX’s actual cash-flow trajectory, moat via Starlink and launch services, and the pace of any government contracts that could offset dilution. The unlock schedule is long and uneven; some insiders may hold, others liquidate. If SpaceX can show durable free cash flow and accelerating revenue diversification, a re-rating remains possible, even after a choppy unlock path.
The bullish rebuttal is that all this dilution and lockup chatter may already be baked into the price, and the company’s growth catalysts (Starlink monetization, contract wins) could trigger a rebound once investors gain visibility.
"The $2.6 trillion valuation cited by the article and repeated by Claude is a massive factual error that undermines the entire premise of the discussion."
Claude, your $2.6T valuation reference is the most dangerous part of this discussion. That figure is not just 'absurd'; it is a hallucination likely derived from a misunderstanding of secondary market tender offers or total addressable market projections. By even entertaining that number, we validate the article's fiction. SpaceX’s actual last reported private valuation was closer to $210 billion. We must stop debating hypothetical IPO pricing as if it originated from a legitimate S-1 filing.
"We should stop debating IPO mechanics for a company that hasn't filed to go public; the article is marketing fiction, not forward guidance."
Gemini's correction on the $210B valuation is essential, but it actually strengthens Claude's core point: even at $210B private, an IPO pop to $2.6T would still represent irrational exuberance that mean-reverts. The real issue isn't whether $2.6T is real—it's that we're debating a fictional IPO scenario as if it's imminent. All four of us are treating a Motley Fool thought experiment as market analysis. The article's actual value is zero unless SpaceX files an S-1.
"Debating hypothetical IPO valuations distracts from illiquidity risks in actual private secondary markets."
Gemini is right that the $2.6 trillion valuation is pure invention from misunderstood tender offers. However, Claude's emphasis on mean-reversion ignores how the article's fictional IPO distracts from real secondary market risks where investors face years of illiquidity without any public disclosure requirements or quarterly earnings visibility.
"Post-IPO dynamics hinge on governance and cash-flow visibility, not dilution timing alone."
Gemini, your correction on the $2.6T figure is essential, but the bigger flaw is treating an IPO as a simple mean-reversion event. If SpaceX ever goes public, the post-IPO path depends less on dilution timing and more on governance, disclosure, and true cash-flow visibility from Starlink and launches. A multi-class cap table or non-GAAP flex could perpetuate overhang and protracted volatility, not a clean re-rating.
The panel consensus is that the article's discussion on SpaceX's IPO, valuation, and dilution is flawed due to SpaceX's current private status and the speculative nature of the article's claims. They agree that the article is not a reliable source of analysis for SpaceX's future as a public company.
None explicitly stated, as the article's content is largely dismissed as fiction.
Treating a hypothetical IPO scenario as imminent and discussing its dilution and valuation without a legitimate S-1 filing.